As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/14/24  Armistice Capital, LLC            SC 13G                 1:82K  SuperCom Ltd.                     Akin Gump Str… Office/FA 
          Steven Boyd³
 6/28/23‡ Armistice Capital, LLC            SC 13D/A    6/27/23    1:55K  Avalo Therapeutics, Inc.          Akin Gump Str… Office/FA 
          Steven Boyd³
 2/10/23  Armistice Capital, LLC            SC 13G                 1:126K Cyclo Therapeutics, Inc.          Akin Gump Str… Office/FA 
          Steven Boyd³
  2/9/23  Armistice Capital, LLC            SC 13D/A               1:54K  Avalo Therapeutics, Inc.          Akin Gump Str… Office/FA 
          Steven Boyd³
 9/23/22  Armistice Capital, LLC            SC 13G                 1:125K Freshpet, Inc.                    Akin Gump Str… Office/FA 
          Steven Boyd³
 8/11/22  Armistice Capital, LLC            SC 13D/A               1:49K  Avalo Therapeutics, Inc.          Akin Gump Str… Office/FA 
          Steven Boyd³
 6/21/22  Armistice Capital, LLC            SC 13G                 2:71K  Tenax Therapeutics, Inc.          Donnelley … Solutions/FA 
          Steven Boyd³
 6/17/22  Armistice Capital, LLC            SC 13D/A               1:46K  Tenax Therapeutics, Inc.          Donnelley … Solutions/FA 
          Steven Boyd³
 5/20/22  Armistice Capital, LLC            SC 13D/A               1:61K  Tenax Therapeutics, Inc.          Akin Gump Str… Office/FA 
          Steven Boyd³
 3/15/22  Armistice Capital, LLC            SC 13D/A               1:56K  Avalo Therapeutics, Inc.          Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:69K  Vanda Pharmaceuticals Inc.        Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:65K  Adamas Pharmaceuticals Inc.       Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:68K  Voyager Therapeutics, Inc.        Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G                 2:66K  Unicycive Therapeutics, Inc.      Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:67K  Biolase, Inc.                     Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:62K  Supernus Pharmaceuticals, Inc.    Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A               2:66K  Lantheus Holdings, Inc.           Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G      2/14/22    2:66K  Inpixon                           Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A    2/14/22    2:72K  Conformis Inc.                    Donnelley … Solutions/FA 
          Steven Boyd³
 2/15/22‡ Armistice Capital, LLC            SC 13G/A    2/14/22    2:67K  Citius Pharmaceuticals, Inc.      Donnelley … Solutions/FA 
          Steven Boyd³

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.